Delivery Order SPE2DB22D3004-SPE2DB25FPJ95
Award Date
2/4/25
Potential Completion Date
2/5/25
Potential Value
$5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award, SPE2DB25D2204|SPE2DB25FTFXT, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,173.83 firm fixed-price delivery order contract, with a completion date of January 8, 2025, is for the supply of 4566861069 - VYVANSE 20 MG CAPSULE 100S. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with an ID of SPE2DB24D1034|SPE2DB25FVZW6, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product, with a ceiling value of $1,783.60 and a period of performance through January 17, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award, identified as SPE2DB22D1106|SPE2DB24FFLQ3, was issued by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp, for the delivery of VYVANSE 50 MG CAPSULE 100S. The contract has a ceiling value of $5,455.56 and an ultimate completion date of September 10, 2024. This award is not set-aside and is a Delivery Order under a Firm Fixed Price contract type. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, has been awarded...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VYVANSE 20 MG CAPSULE 100S. The contract has a ceiling value of $1,600.66 and a period of performance through April 29, 2024. It is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
This federal contract award, with ID SPE2DX15D1053|SPE2DX25F6EWD, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $5,644.80, is for the delivery of 4566719025 VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen Drug Corp with the DLA Troop Support Medical. This IDC serves...
This federal contract award, with an ID of SPE2DB24D1104|SPE2DB25FXWD7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,858.54, is for the delivery of VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, with an ID of SPE2DB20D1100|SPE2DB25FZ20U, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $2,784.96, is a delivery order for the supply of 4566529414 - VYVANSE 10 MG CAPSULE 100S. The contract has a firm fixed price and an ultimate completion date of November 25, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
The federal contract award SPE2DB24D1205/SPE2DB24FCULM was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VYVANSE 20 MG CAPSULE 100S. The contract has a ceiling value of $3,017.00 and is a Firm Fixed Price Delivery Order with a completion date of September 9, 2024. Amerisourcebergen has been awarded this contract under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
This federal contract award, SPE2DB20D2104|SPE2DB25FMEGR, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,764.33, is for the delivery of VYVANSE 50 MG CAPSULE 100S, a prescription medication. This appears to be a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating it was competitively awarded....
This federal contract award, identified as SPE2DB22D2007|SPE2DB25FH8QE, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,023.52, is a delivery order with a firm fixed price and an ultimate completion date of January 30, 2025. The contract is for the supply of 4567089484 units of VYVANSE 60 MG CAPSULE 100S, a medication used in the treatment of various medical...